Caxton Associates (New York)’s Chimerix, Inc. CMRX Stock Holding History

Caxton Associates (New York)’s Portfolio CMRX Stock Details CMRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-69,229	Closed	-$83.8K	–	627
2023 Q2	$83.8K	Sell	69,229 -101,606	-59%	-$129K	0.01%	459
2023 Q1	$215K	Hold	170,835	–	–	0.03%	408
2022 Q4	$318K	Buy	170,835 +12,165	+8%	+$23.8K	0.02%	314
2022 Q3	$306K	Buy	158,670 +99,772	+169%	+$224K	0.04%	324
2022 Q2	$123K	Buy	+58,898	New	+$189K	0.01%	505

Other funds holding CMRX

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

MAM

Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Caxton Associates (New York)'s CMRX Position: Q3 2023 in Review

Caxton Associates (New York) sold out of Chimerix, Inc. (CMRX) in Q3 2023, closing a stake of 69,229 shares — an estimated $83.8K sold.

Caxton Associates (New York) first reported a position in CMRX in Q2 2022 and held it in 5 quarters. The position peaked at $318K in Q4 2022. 78 funds tracked by Wall St. Rank hold CMRX as of Q3 2023.

Caxton Associates (New York) reported no remaining Chimerix, Inc. position as of Q3 2023 after selling out during the quarter.
Caxton Associates (New York) sold 69,229 Chimerix, Inc. shares in Q3 2023, an estimated $83.8K.
Caxton Associates (New York) first reported a position in Chimerix, Inc. in Q2 2022 and held it in 5 quarters.
Caxton Associates (New York)'s Chimerix, Inc. position peaked at $318K in Q4 2022.
78 funds tracked by Wall St. Rank held Chimerix, Inc. as of Q3 2023.

Based on Caxton Associates (New York)'s 13F filing for Q3 2023, filed 14 Nov 2023.